22652964|t|Nucleoside-5'-phosphorothioate analogues are biocompatible antioxidants dissolving efficiently amyloid beta-metal ion aggregates.
22652964|a|Amyloid beta (Abeta) peptide is known to precipitate and form aggregates with zinc and copper ions in vitro and, in vivo in Alzheimer's disease (AD) patients. Metal-ion-chelation was suggested as therapy for the metal-ion-induced Abeta aggregation, metal-ion overload, and oxidative stress. In a quest for biocompatible metal-ion chelators potentially useful for AD therapy, we tested a series of nucleoside 5'-phosphorothioate derivatives as re-solubilization agents of Cu(+)/Cu(2+)/Zn(2+)-induced Abeta-aggregates, and inhibitors of Fenton reaction in Cu(+) or Fe(2+)/H(2)O(2) system. The most promising chelator in this series was found to be APCPP-gamma-S. This nucleotide was found to be more efficient than EDTA in re-solubilization of Abeta(40)-Cu(2+) aggregates as observed by the lower diameter, d(H), (86 vs. 64 nm, respectively) obtained in dynamic light scattering measurements. Likewise, APCPP-gamma-S dissolved Abeta(40)-Cu(+) and Abeta(42)-Cu(2+)/Zn(2+) aggregates, as monitored by (1)H-NMR and turbidity assays, respectively. Furthermore, addition of APCPP-gamma-S to nine-day old Abeta(40)-Cu(2+)/Zn(2+) aggregates, resulted in size reduction as observed by transition electron microscopy (diameter reduction from 2.5 to 0.1 mum for Abeta(40)-Cu(2+) aggregates). APCPP-gamma-S proved to be more efficient than ascorbic acid and GSH in reducing OH radical production in Fe(2+)/H(2)O(2) system (IC(50) values 85, 216 and, 92 muM, respectively). Therefore, we propose APCPP-gamma-S as a potential AD therapy capable of both reducing OH radical production and re-solubilization of Abeta(40/42)-M(n+) aggregates.
22652964	0	30	Nucleoside-5'-phosphorothioate	Chemical	-
22652964	95	107	amyloid beta	Gene	351
22652964	130	142	Amyloid beta	Gene	351
22652964	144	149	Abeta	Gene	351
22652964	217	223	copper	Chemical	MESH:D003300
22652964	254	273	Alzheimer's disease	Disease	MESH:D000544
22652964	275	277	AD	Disease	MESH:D000544
22652964	279	287	patients	Species	9606
22652964	289	294	Metal	Chemical	MESH:D008670
22652964	342	347	metal	Chemical	MESH:D008670
22652964	360	365	Abeta	Gene	351
22652964	379	384	metal	Chemical	MESH:D008670
22652964	450	455	metal	Chemical	MESH:D008670
22652964	493	495	AD	Disease	MESH:D000544
22652964	527	557	nucleoside 5'-phosphorothioate	Chemical	-
22652964	601	606	Cu(+)	Chemical	MESH:D003300
22652964	607	613	Cu(2+)	Chemical	-
22652964	614	620	Zn(2+)	Chemical	-
22652964	629	634	Abeta	Gene	351
22652964	684	689	Cu(+)	Chemical	MESH:D003300
22652964	693	699	Fe(2+)	Chemical	-
22652964	700	708	H(2)O(2)	Chemical	MESH:D006861
22652964	776	790	APCPP-gamma-S.	Chemical	-
22652964	843	847	EDTA	Chemical	MESH:D004492
22652964	882	888	Cu(2+)	Chemical	-
22652964	1031	1044	APCPP-gamma-S	Chemical	-
22652964	1065	1070	Cu(+)	Chemical	MESH:D003300
22652964	1075	1084	Abeta(42)	Gene	351
22652964	1085	1091	Cu(2+)	Chemical	-
22652964	1092	1098	Zn(2+)	Chemical	-
22652964	1128	1131	1)H	Chemical	-
22652964	1197	1210	APCPP-gamma-S	Chemical	-
22652964	1237	1243	Cu(2+)	Chemical	-
22652964	1244	1250	Zn(2+)	Chemical	-
22652964	1390	1396	Cu(2+)	Chemical	-
22652964	1410	1423	APCPP-gamma-S	Chemical	-
22652964	1457	1470	ascorbic acid	Chemical	MESH:D001205
22652964	1475	1478	GSH	Chemical	MESH:D005978
22652964	1491	1501	OH radical	Chemical	-
22652964	1516	1522	Fe(2+)	Chemical	-
22652964	1523	1531	H(2)O(2)	Chemical	MESH:D006861
22652964	1612	1625	APCPP-gamma-S	Chemical	-
22652964	1641	1643	AD	Disease	MESH:D000544
22652964	1677	1687	OH radical	Chemical	-
22652964	1724	1729	Abeta	Gene	351
22652964	Negative_Correlation	MESH:D008670	MESH:D000544
22652964	Association	MESH:D003300	MESH:D008670
22652964	Association	MESH:D000544	351
22652964	Positive_Correlation	MESH:D008670	351
22652964	Association	MESH:D003300	351

